Supernus Pharmaceuticals Entered Into Settlement And License Agreements With Apotex Inc. And Apotex Corp On June 21
Portfolio Pulse from Benzinga Newsdesk
Supernus Pharmaceuticals has entered into settlement and license agreements with Apotex Inc. and Apotex Corp on June 21, according to an SEC filing.
June 23, 2023 | 8:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Supernus Pharmaceuticals' settlement and license agreements with Apotex Inc. and Apotex Corp may have a positive impact on the company's stock.
The settlement and license agreements with Apotex Inc. and Apotex Corp may resolve any ongoing legal disputes and provide Supernus Pharmaceuticals with additional licensing revenue. This could have a positive impact on the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100